Skip to main content
Quest Diagnostics

Maternal Rates of Alloimmunization at Initiation of Pregnancy Care: Insights from a National Cohort

2024 SMFM Pregnancy Meeting

The Society for Maternal-Fetal Medicine

National Harbor, MD, Feb 10-14, 2024

Poster presentation: Maternal Rates of Alloimmunization at Initiation of Pregnancy Care: Insights from a National Cohort

Authors: Sugrue R, Federspiel J, Abels E,  Louie J, Chen Z, Moises KJ, Jr., Alagia DP, Kaufman HW

Specialty: Women's health, OB, GYN, Infectious disease

Related content

Publication
Editorial: Host-pathogen interactions during pregnancy: Effects on maternal health, pregnancy outcomes, and fetal development
Publication
Chlamydia trachomatis and Neisseria gonorrhoeae in Pregnancy: Trends in United States, 2010-2018
Conference Presentation
Frequency of Incidental Maternal Mosaic and Variant Turner Syndrome Detected by NIPT in a Pregnant Cohort
Test FAQ
Maternal Serum AFP
Test FAQ
Serum Pregnancy Tests
Test FAQ
QNatal Advanced

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.